220.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$218.36
Offen:
$216.12
24-Stunden-Volumen:
10.74M
Relative Volume:
0.97
Marktkapitalisierung:
$276.83B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
48.57
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+13.16%
1M Leistung:
+37.30%
6M Leistung:
+116.65%
1J Leistung:
+195.24%
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
220.40 | 274.27B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,281.23 | 494.45B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
307.24 | 238.82B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,428.17 | 183.95B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
224.36 | 34.02B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research stock rises after-hours as Susquehanna lifts target to $250 - TechStock²
Top Stock Reports for Microsoft, Eli Lilly & Lam Research - Yahoo Finance
What to expect from Lam Research’s Q2 2025 earnings report - MSN
Lam Research (LRCX): Bernstein Raises Price Target to $225 | LRC - GuruFocus
Sumitomo Mitsui Trust Group Inc. Raises Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Meeder Asset Management Inc. - MarketBeat
What to Expect From Lam Research’s Q2 2025 Earnings Report - Barchart.com
Lam Research (LRCX) Needs to "Put Up Plants," Says Jim Cramer - Finviz
Lam Research (LRCX) Needs to “Put Up Plants,” Says Jim Cramer - Insider Monkey
Q3 Rundown: Lam Research (NASDAQ:LRCX) Vs Other Semiconductor Manufacturing Stocks - Barchart.com
Lam Research Corporation $LRCX Shares Acquired by New York State Teachers Retirement System - MarketBeat
Lam Research stock pops on Mizuho target raise as Wall Street eyes Jan. 28 earnings call - TechStock²
Lam Research Stock Jumps Amid Analysts’ Enhancing Price Targets - StocksToTrade
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 7,890 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by MASTERINVEST Kapitalanlage GmbH - MarketBeat
Ferguson Wellman Capital Management Inc. Purchases Shares of 6,750 Lam Research Corporation $LRCX - MarketBeat
Cantor Fitzgerald Raises Lam Research’s Price Target Signaling Growth - StocksToTrade
Lam Research stock jumps after target hikes as chip rally hits full stride - TechStock²
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research Stock: A Deep Dive Into Analyst Perspectives (24 Ratings) - Benzinga
Intel, Lam Research among market cap stock movers on Friday By Investing.com - Investing.com South Africa
Intel, Lam Research among market cap stock movers on Friday - Investing.com
Mizuho Raises Price Target for Lam Research (LRCX) to $220, Main - GuruFocus
Why Is Lam Research (LRCX) Stock Soaring Today - Finviz
Lam Research (NASDAQ:LRCX) Reaches New 1-Year HighHere's Why - MarketBeat
Lam Research stock hits all-time high at 210.45 USD By Investing.com - Investing.com Nigeria
Lam Research stock hits all-time high at 210.45 USD - Investing.com
Lam Research Corporation $LRCX Shares Bought by Oregon Public Employees Retirement Fund - MarketBeat
Lam Research (NASDAQ:LRCX) Powers Chip Tools In Nasdaq 100 Index - Kalkine Media
Lam Research Corporation Announces December Quarter Financial Conference Call - Sahm
How Lam Research Corporation stock reacts to global recession fears2025 Trading Volume Trends & Growth Oriented Trading Recommendations - ulpravda.ru
Lam Research stock slips after-hours even as Cantor lifts target to $265 - TechStock²
Lam Research (NASDAQ:LRCX) Shares Down 1%What's Next? - MarketBeat
Applied Materials, KLA Corporation, Lam Research, Seagate Technology, and Western Digital Stocks Trade Down, What You Need To Know - Yahoo Finance
WD Rutherford LLC Acquires New Holdings in Lam Research Corporation $LRCX - MarketBeat
Jim Cramer Notes That Lam Research Is One of the Stocks He Likes "So Much" - Finviz
Jim Cramer Notes That Lam Research Is One of the Stocks He Likes “So Much” - Insider Monkey
9,465 Shares in Lam Research Corporation $LRCX Bought by Realta Investment Advisors - MarketBeat
Park Avenue Securities LLC Purchases 5,322 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation Announces December Quarter Financial Co - GuruFocus
Lam Research (NASDAQ:LRCX) Trading Down 1.8%Here's What Happened - MarketBeat
Want to hear Lam Research’s financial call? Here’s when to tune in - Stock Titan
Lam Research Corporation Stock (LRCX) Opinions on Recent 'Buy' Rating and AI Demand - Quiver Quantitative
Lam Research stock slips after two-day rally as traders weigh fresh Buy call and CES headlines - TechStock²
Lam Research (LRCX) Is Up 19.1% After Analysts Spotlight Its AI-Focused Chipmaking Tools - Yahoo Finance
SkyOak Wealth LLC Invests $864,000 in Lam Research Corporation $LRCX - MarketBeat
Securian Asset Management Inc. Lowers Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
First Merchants Corp Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Childress Capital Advisors LLC - MarketBeat
Lam Research, Micron Tech among market cap stock movers on Tuesday - Investing.com
Lam Research (NASDAQ:LRCX) Shares Up 6.3%What's Next? - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):